Brief: Simcere Pharmaceutical Expects 1H 2026 Revenue Of RMB4,550 Million-RMB4,610 Million
30/07/2026 16:38
BRIEF-Simcere Pharmaceutical Expects 1H 2026 Revenue Of RMB4,550 Million-RMB4,610 Million July 30 (Reuters) - Simcere Pharmaceutical Group Ltd 2096.HK:
EXPECTS 1H 2026 REVENUE OF RMB4,550 MILLION-RMB4,610 MILLION, UP 26.9%-28.6%
Further company coverage: 2096.HK
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Simcere Pharmaceutical
See all newsBrief: Simcere Pharmaceutical Announces Approval For Marketing Of Yingmule In China By NMPA
Simcere Pharmaceutical jumps most in two months on Roche tie-up
Roche signs global licensing pact for Simcere's experimental blood cancer drug (updated)
Roche signs global licensing pact for Simcere's B-cell cancer drug candidate
Brief: Simcere Pharmaceutical Enters Exclusive Global Licensing Agreement With Roche For SIM0660